Understanding healthcare providers' preferred attributes of pediatric pneumococcal conjugate vaccines in the United States

As higher-valent pneumococcal conjugate vaccines (PCVs) become available for pediatric populations in the US, it is important to understand healthcare provider (HCP) preferences for and acceptability of PCVs. US HCPs (pediatricians, family medicine physicians and advanced practitioners) completed an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human vaccines & immunotherapeutics 2024-12, Vol.20 (1), p.2325745
Hauptverfasser:	Mohanty, Salini, Tsai, Jui-Hua, Ning, Ning, Martinez, Ana, Verma, Rishi P., Heisen, Marieke, Weaver, Jessica, Feemster, Kristen A., Chun, Bianca, Weiss, Thomas W., Schmier, Jordana K
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult attitudes behaviors Child Child, Preschool Cross-Sectional Studies discrete choice experiment Female General Practitioners Heptavalent Pneumococcal Conjugate Vaccine Humans Infant knowledge Male pediatric vaccines Pneumococcal pneumococcal conjugate vaccines pneumococcal disease Pneumococcal Infections - prevention & control Pneumococcal Vaccines provider preferences Serogroup Streptococcus pneumoniae Survey United States Vaccines, Conjugate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	As higher-valent pneumococcal conjugate vaccines (PCVs) become available for pediatric populations in the US, it is important to understand healthcare provider (HCP) preferences for and acceptability of PCVs. US HCPs (pediatricians, family medicine physicians and advanced practitioners) completed an online, cross-sectional survey between March and April 2023. HCPs were eligible if they recommended or prescribed vaccines to children age
ISSN:	2164-5515 2164-554X 2164-554X
DOI:	10.1080/21645515.2024.2325745